Viewing Study NCT03525392


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-01-29 @ 3:53 PM
Study NCT ID: NCT03525392
Status: TERMINATED
Last Update Posted: 2023-12-12
First Post: 2018-05-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Sponsor: Ipsen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma View
None Colorectal Cancer View
None Gastric Cancer View
None Squamous Cell Carcinoma of the Head and Neck View
None Bone Cancer View
None Advanced Cancer View
None Recurrent Disease View
None Metastatic Tumours View
Keywords: